Scrub typhus Vulnerable condition Vulnerable Empowerment Advocacy Ethic
Conditions
Interventions
Group 1a. Women or children who participated in the EXIST or START studies (including participants in EXIST’s control group)
Group 1b. their spouse/partners,
parents/guardians and/or their family members/key supporters.
Study A: Eschar investigations to improve diagnostics,
understand early immune responses and characterize strains for vaccines in scrub typhus (EXIST)
Ref: OXTREC ref number: 46-
FTMEC number: 16-
065
Study B: The Scrub Typhus Antibiotic Resistance Trial (START)
Comparing Doxycycline and Azithromycin Treatment Modalities in Areas of Reported Antimicrobial Resistance for Scrub Typhus
OXTREC ref
17,
055
,Researchers,
study administrators/coordinators and frontline healthcare workers who have been involved in the above studies,
members of the Ethics Committees (EC) in Chiang Rai ,Key representatives in communities where group 1 participants live or come from.
(Potential key representatives in communities include community le
primary healthcare unit directors and health volunteers,
boarding school teachers,
community and non-
governmental organisations).
Other,Other,Other
Women or children who participated in the EXIST or START studies or their family members,Researchers,
study administrators/coordinators and frontline healthcare workers,Key representatives in communities where group 1 participants live or come from.
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Age
7 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants will be male or female, aged 7 years and above, who have provided written informed consent +/- assent, and who belong to one of the following three groups: Group 1. 1a. Women or children who participated in the EXIST or START studies (including participants in EXIST’s control group) 1b. their spouse/partners, parents/guardians and/or their family members/key supporters. Group 2. Researchers, study administrators/coordinators and frontline healthcare workers who have been involved in the above studies, and members of the Ethics Committees (EC) in Chiang Rai. Group 3. Stakeholders in communities where group 1 participants live or come from, and other community members. Our potential key stakeholders include community leaders, primary healthcare unit directors and health volunteers, boarding school teachers, community and non-governmental organisations.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a context-sensitive ethical account 3 years from date of ethics approval In-depth interviews (IDIs) and focus group discussion (FGDs),Framework of the specific vulnerabilities 3 years from date of ethics approval In-depth interviews (IDIs) and focus group discussion (FGDs),Sources of support/empowerment 3 years from date of ethics approval In-depth interviews (IDIs) and focus group discussion (FGDs) | — |
Secondary
| Measure | Time frame |
|---|---|
| A map of key points of how potential vulnerabilities-abilities are identified 3 years from date of ethics approval In-depth interviews (IDIs) and focus group discussion (FGDs),An account of how to respond to participant vulnerabilities and leverage support/empowerment 3 years from date of ethics approval In-depth interviews (IDIs) and focus group discussion (FGDs),An account of how to respond to ethical challenges related to vulnerabilities of participants 3 years from date of ethics approval In-depth interviews (IDIs) and focus group discussion (FGDs) | — |
Countries
Thailand
Contacts
Public ContactPhaikyeong Cheah
Oxford University
Outcome results
None listed